Skip to content
etf.net

Launched

ERShares Private-Public Crossover ETF

XOVRNasdaqB

$19.62−0.20 (−1.01%)

At close: Nov 2, 2026, 4:00 PM ET

B57/ 100

Rank 4 of 12 in Listed Private Markets

B57/100Rank 4 of 12inListed Private Markets
Intraday session: down, 79 prints from 19.82 to 19.62. Range 19.62 to 20.18. Use the arrow keys to read each point.19.7019.9020.0020.1020.2010 AM12 PM2 PM4 PM
Expense ratio
0.83%
Fund size
$1.39B
1Y total return
−7.0%
Yield · Last 12 months
0.00%
Holdings
33
Avg volume · 30D
4.17M sh
52W range
low $16.37high $22.81
Launched

The ETF.net XOVR Grade

Based on 5 of 6 pillars

B

Score 57 out of 100

Category
Listed Private Markets⁠
Rank
4 of 12
Six-pillar profile for XOVR. Scores out of 100: Cost 76, Risk 26, Mission not scored, Tradability 59, Holdings 37, Durability 72. Strongest: Cost (76). Weakest: Risk (26). Based on 5 of 6 pillars.

Score 57 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A76 out of 100
    Rank 3 of 12

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    D26 out of 100
    Rank 10 of 12

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B59 out of 100
    Rank 5 of 12

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    D37 out of 100
    Rank 9 of 11

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    A72 out of 100
    Rank 4 of 12

Our read on XOVR

ETF.net Research

In short

BA regular brokerage account, a slice of SpaceX. XOVR wraps about 30 public growth names around select late-stage private stakes held through special-purpose vehicles, with no accredited-investor hoops. Fee: 1.81%, no waiver.

Stated mandate

The fund seeks long-term capital appreciation through a broader crossover strategy combining public equities with select private-company exposure.

Why people hold it

  • Roughly 30 listed growth names plus stakes in late-stage private companies like SpaceX, held through special-purpose vehicles inside a 1940 Act ETF.prnewswire.com
  • No accredited-investor status, capital calls or lockups. Private-market access arrives in a brokerage account, which is the structure's whole reason to exist.prnewswire.com
  • 1.81%, no waiver. Steep next to index funds, yet below the median for listed private-markets funds, a category where BIZD's 9.69% marks the high end.
  • A billion-dollar-plus fund that trades actively, unusual for a niche thematic strategy, and listed since 2017.

Worth knowing

  • Private stakes have no closing price. They are marked by the fund's valuation process and can reprice on a funding round or an IPO rather than day to day.
  • About 30 holdings, with the private sleeve concentrated in a single name, so one company's mark can move the fund more than a broad equity ETF would.prnewswire.com
  • Cheaper shelf-mates exist, GPZ at 0.40% and GTPE at 0.50%, but neither is built around direct late-stage private stakes.

XOVR Holdings

Holdings pillarD37 out of 100Rank 9 of 11 in Listed Private Markets
Asset class
Stocks
Holdings
33
Top-10 weight
57%
Largest holding
SPV Exposure to SpaceX LP17.5%

Sectors

  • Technology36.5%
  • Communication23.3%
  • Health Care21.9%
  • Financials9.4%
  • Consumer Discretionary4.6%
  • Industrials4.3%

Geography

  • United States100.00%
The fund’s holdings, weight-ordered — page 1 of 3.
#TickerCompanyWeight %SharesMarket valueHeld by ETFs
1No dataSPV Exposure to SpaceX LP17.51%0$244M1
2NVDANVIDIA Corp.9.36%636,600$130M848
3GOOGLAlphabet Inc. Class A5.30%263,749$73.8M707
4METAMeta Platforms Inc. Class A4.56%103,285$63.5M708
5CARTMaplebear Inc.4.30%1,060,967$59.9M221
6UIUbiquiti Inc.3.74%92,291$52M109
7TOSTToast Inc. Class A3.62%1,589,540$50.4M199
8GMEDGlobus Medical Inc. Class A3.32%592,140$46.2M160
9VEEVVeeva Systems Inc. Class A2.89%128,546$40.2M335
10EXELExelixis Inc.2.68%538,382$37.4M251
11PRPermian Resources Corp.2.61%1,394,353$36.3M217
12DASHDoorDash Inc. Class A2.55%197,967$35.4M347
13AFRMAffirm Holdings Inc.2.50%472,770$34.7M172
14NBIXNeurocrine Biosciences Inc.2.49%236,908$34.6M250
15NTRANatera Inc.2.45%82,387$34.1M239

Showing 1–15 of 33 holdings

XOVR Performance

Launched Nov 7, 2017

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
XOVR$9,301
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. XOVR $9,301. SPY $11,199. Use the arrow keys to read each point.$8,000$9,000$10,000$11,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for XOVR. Periods over one year show the average yearly return.
PeriodXOVR
Year to date−1.6%
1 month−7.2%
3 months+6.6%
1 year−7.0%
3 yearsHistory unavailableper yearNo data
5 yearsHistory unavailableper yearNo data
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for XOVR
YearReturn barXOVR
2026 YTD−1.6%
2025+11.8%
2024+27.4%

History from Aug 5, 2024

XOVR in the news

XOVR Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
0.00%Last 12 months
Payout per share
NoneLast 12 months

No distributions in the last 12 months.

Distribution history

Payments through 2021

One bar per payment. 5 payments from 2017 to 2021. Dec 22, 2017 $0.01; Dec 18, 2018 $0.52; Dec 19, 2019 $0.01; Dec 21, 2020 $1.65; Dec 21, 2021 $8.73. Use the arrow keys to read each point.20172018201920202021
Ex-datePay dateAmount per share
Dec 21, 2021Dec 28, 2021$8.73
Dec 21, 2020Dec 23, 2020$1.65
Dec 19, 2019Dec 23, 2019$0.01
Dec 18, 2018Dec 20, 2018$0.52
Dec 22, 2017Dec 28, 2017$0.01

XOVR Risk

Risk pillarD26 out of 100Rank 10 of 12 in Listed Private Markets
How much the fund’s monthly returns vary, scaled to a year.
24.2%
Annualised · 26 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.43
vs 3-month T-bills · 26 months to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−25.2%
26 months · trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.20
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

XOVR Cost

Compare XOVR and GPZ

Overpaying vs GPZ, cheapest in Listed Private Markets

$7,769

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • XOVR 0.83%

    $15,859

  • GPZ 0.40% Cheapest

    $8,090

$10,000
30 years

Cost over time

  • XOVR 0.83%
  • GPZ 0.40%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530XOVR $15,859GPZ $8,090

Year by year

YearXOVRGPZOverpaying
10$1,474$723$751
20$5,581$2,793$2,788
30$15,859$8,090$7,769

Other funds in Listed Private Markets

See others